MK
Mitchell Kapoor HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
CRISPR Therapeutics
CRSP
$4.8B
| $52.74 | $80 |
52%
upside
| Buy | 28 days ago |
|
2
Halozyme
HALO
$8.59B
| $73.40 | $75 |
2%
upside
| Buy | 29 days ago |
|
3
Ionis Pharmaceuticals
IONS
$9.46B
| $59.35 | $65 |
10%
upside
| Buy | 1 month ago |
|
|
ALMS
4
Alumis Inc. Common Stock
ALMS
$475M
| $4.60 | $14 |
204%
upside
| Buy | 1 month ago |
|
5
Korro Bio
KRRO
$264M
| $28.09 | $100 |
256%
upside
| Buy | 1 month ago |
|
|
ORKA
6
Oruka Therapeutics, Inc. Common Stock
ORKA
$561M
| $14.97 | $45 |
201%
upside
| Buy | 1 month ago |
|
7
Legend Biotech
LEGN
$6.46B
| $34.99 | $75 |
114%
upside
| Buy | 1 month ago |
|
8
Tyra Biosciences
TYRA
$647M
| $12.14 | $30 |
147%
upside
| Buy | 2 months ago |
|
9
Summit Therapeutics
SMMT
$17.7B
| $23.80 | $44 |
85%
upside
| Buy | 2 months ago |
|
10
Sarepta Therapeutics
SRPT
$1.93B
| $18.46 | $10 |
46%
downside
| Sell | 2 months ago |
|
11
Intellia Therapeutics
NTLA
$1.25B
| $11.62 | $30 |
158%
upside
| Buy | 2 months ago |
|
12
CytomX Therapeutics
CTMX
$346M
| $2.10 | $5 |
138%
upside
| Buy | 3 months ago |
|
13
Lexeo Therapeutics
LXEO
$268M
| $4.97 | $15 |
202%
upside
| Buy | 3 months ago |
|
14
Neurogene
NGNE
$280M
| $19.61 | $45 |
129%
upside
| Buy | 3 months ago |
|
15
Cartesian Therapeutics
RNAC
$260M
| $10 | $40 |
300%
upside
| Buy | 4 months ago |
|
16
Abeona Therapeutics
ABEO
$352M
| $6.86 | $15 |
119%
upside
| Buy | 5 months ago |
|